Position in VIR
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$824,320
New position
Shares Held
92,000
first reported quarter
Ownership
0.055%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026THOMPSON SIEGEL & WALMSLEY LLC holds $58,024,470 across 5 Biotechnology names. VIR ranks #4 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
233,694 | $44,179,850 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,676 | $9,793,984 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,437 | $2,874,377 | |
| 4 | VIR |
Vir Biotechnology, Inc.
This page
|
92,000 | $824,320 | |
| 5 | FENC |
Fennec Pharmaceuticals Inc.
|
57,226 | $351,939 |
All Filings in VIR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $824,320 | 92,000 | Shares | Defined | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||